Microcin MccI47 selectively inhibits enteric bacteria and reduces carbapenem-resistant Klebsiella pneumoniae colonization in vivo when administered via an engineered live biotherapeutic

Document Details

Document Type
Pub Defense Publication
Publication Date
Sep 29, 2022
Source ID
10.1080/19490976.2022.2127633

Entities

People

  • Benedikt M Mortzfeld
  • Beth A. McCormick
  • Corinna Bang
  • Haley L. Dupre
  • Jacob Palmer
  • Mark W Silby
  • Regino Mercado–Lubo
  • Shakti K. Bhattarai
  • Vanni Bucci

Organizations

  • Congressionally Directed Medical Research Programs
  • German Research Foundation
  • Kiel University
  • University of Massachusetts Dartmouth
  • University of Oxford